Bio-Rad Reports Third-Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/21/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Bio-Rad Labs (BIO) Misses Q3 EPS by 24c
November 1, 2018 4:39 PM EDTBio-Rad Labs (NYSE: BIO) reported Q3 EPS of $0.91, $0.24 worse than the analyst estimate of $1.15. Revenue for the quarter came in at $545.1 million versus the consensus estimate of $538.68 million.
2018 Financial Outlook
For the full year 2018, the company is reiterating the previous currency-neutral growth... More
